134 related articles for article (PubMed ID: 7456428)
1. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons].
Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M
Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
[TBL] [Abstract][Full Text] [Related]
3. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
Light PA; Preece AW; Waldron HA
Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
[TBL] [Abstract][Full Text] [Related]
4. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
5. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
[TBL] [Abstract][Full Text] [Related]
6. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
[TBL] [Abstract][Full Text] [Related]
8. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
9. [Malignant lymphomas in primates and the principles of their morphological diagnosis (on a baboon model of malignant lymphomas)].
Lapin BA; Iakovleva LA; Indzhiia LV
Arkh Patol; 2007; 69(4):38-41. PubMed ID: 17926576
[TBL] [Abstract][Full Text] [Related]
10. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
11. The macrophage electrophoretic mobility test for malignancy.
Lubran MM
Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
[No Abstract] [Full Text] [Related]
12. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
13. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
Zhao BH; Hu JK; Liang JX
Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
[No Abstract] [Full Text] [Related]
14. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
[TBL] [Abstract][Full Text] [Related]
15. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
16. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
[TBL] [Abstract][Full Text] [Related]
17. KCl carcinoma extracts as tumor antigens in the electrophoretic mobility test: clinical evaluation.
Muhrer KH; Link KH
Cancer Detect Prev; 1983; 6(1-2):101-6. PubMed ID: 6883371
[TBL] [Abstract][Full Text] [Related]
18. Spontaneously generated non-Hodgkin's lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species).
Hubbard GB; Moné JP; Allan JS; Davis KJ; Leland MM; Banks PM; Smir B
Lab Anim Sci; 1993 Aug; 43(4):301-9. PubMed ID: 7901450
[TBL] [Abstract][Full Text] [Related]
19. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.
Shenton BK; Hughes D; Field EJ
Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280
[TBL] [Abstract][Full Text] [Related]
20. [The macrophage electrophoresis mobility (MEM) test for detection of cell sensitivity: technical analyses. I. Guinea pig peritoneal cells as indicator cells in the MEM test].
Gryschek G; Schlott B; Strecker K
Acta Biol Med Ger; 1982; 41(9):837-46. PubMed ID: 7164703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
